Effect of empagliflozin with or without carvedilol on tricuspid regurgitation and right ventricular remodeling: PROVE trial. (PubMed, J Cardiovasc Imaging) - Sep 16, 2026 - P3 | "Carvedilol SR, empagliflozin, or their combination showed no significant reduction in RV volumes, but empagliflozin significantly reduced TR severity in patients with functional TR."
Journal • Atrial Fibrillation • Cardiovascular • Diabetes • Metabolic Disorders
|
|
Chi Young Shim; Dong Hyun Yang; Duk-Hyun Kang; Ga Yun Kim; Hyung-Kwan Kim; In-Chang Hwang; Jong Eun Lee; Jong-Min Song; Sahmin Lee; So-Min Lim; Sung-Cheol Yun; Sung-Ji Park; Yeonyee Elizabeth Yoon
|